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ABSTRACT 
One method of treatment for patients with elevated serum 
cholesterol levels (hypercholesterolemia) is the oral 
administration of an anion exchange resin to adsorb bile acids 
in the gastrointestinal tract. The resins used successfully 
to date have been mainly synthetic ones, whereas anion 
exchange derivatives of cellulose have not been shown to be 
effective. 
Alkyl quaternary amino (QA) cellulose ion exchangers were 
prepared from hydroxypropylated regenerated cellulose (HP 
IndionR). Their capacities for chelate anions were measured 
in the presence of a background of chloride ions at 
physiological concentration. It was shown that butyl QA 
cellulose was ineffective at binding chelate anions. However, 
alkyl QA celluloses with alkyl groups longer than butyl (octyl 
and dodecyl) bound chelate anions in preference to the 
chloride ions and greatly improved capacities were obtained. 
The capacities of the octyl and dodecyl QA celluloses were 
dependent on the cross-linking present in the HP Indion used. 
If the cross-linking was greater than the 15% used in HP5 
Indion, then the capacity for binding chelate dropped off. A 
significant increase in substitution level and decrease in 
swollen volume were obtained by reprocessing the alkyl QA 
cellulose ion exchangers and this improved their chelate 
binding capacities. 
The alkyl QA celluloses were all prepared by first attaching 
chemically reactive epoxide groups to HP Indion and then 
reacting those epoxide groups with a tertiary amine (N,N-
dimethyl-N-alkylamine) to form the quaternary amino cellulose. 
These two steps were repeated for the reprocessed products. 
The optimum conditions for epoxidation of HP5 Indion were 
shown to be 48 hours at 4-6°C in 6% sodium hydroxide with 
excess epichlorohydrin. In the reprocessing step, where this 
reaction was used a second time, 24 hours was sufficient to 
reach maximum epoxidation levels. When coupling the N,N-
dimethyl-N-alkylamine to the epoxide cellulose it was 
necessary to use aqueous ethanol as a solvent. The ethanol 
concentration was dependent on the size of the alkyl group. 
For N,N-dimethyl-N-dodecylamine a concentration of greater 
than 60% ethanol was required. For larger amines considerable 
hydrolysis of the epoxide groups occured during coupling. 
This was avoided almost completely in the first coupling step 
by half-neutralising the amine with hydrochloric acid, to 
lower the pH and buffer the reaction. The optimum coupling 
time and temperature were shown to be 10 hours at 70°C. 
As a result of optimising these processing steps the 
substitution level obtained for dodecyl QA cellulose was 
increased from 0.83 to 1.14 meq/g at the end of the first 
stage and from 1.18 to 1.50 meq/g with the reprocessed 
product. 
A range of alkyl QA celluloses were prepared using the optimum 
conditions found for dodecyl QA cellulose. Octyl and dodecyl 
QA celluloses prepared on HP7 Indion were shown to have higher 
capacities for cholate than cholestyramine and colestipol 
(ColestidR) at cholate concentrations less than 6 mmol/L. The 
dodecyl QA cellulose had superior capacities at all chelate 
concentrations (0-15 mmol/L) when measured on the basis of the 
volume of the ion exchanger used. In contrast, cholestyramine 
and colestipol had higher capacities for deoxycholate anions 
than either of the cellulose products, except when the 
residual concentration of deoxycholate was very low (less than 
0.5 mmol/L). Cholestyramine and colestipol bound deoxycholate 
efficiently (97-99%) when the residual concentration was 
between 5-10 mmol/L, but not chelate (29-48%). However the 
alkyl QA celluloses bound deoxycholate and chelate with very 
high efficiency (82-138%). 
To compare the efficiencies of the ion exchangers at low 
concentrations a more sensitive test was developed utilising a 
mixture of conjugated bile salts, similar in composition to 
that found in the human duodenum. This was equilibrated with 
samples of each ion exchanger and then analysed by HPLC. 
Methyl and butyl QA celluloses were the least effective at 
reducing the concentrations of the bile salts, however they 
still performed as well as colestipol. The capacity of octyl 
QA cellulose was much better than the methyl or butyl QA 
celluloses, indicating the importance of the hydrophobic alkyl 
chain. Cholestyramine had a similar capacity to the octyl QA 
cellulose, except that it was not as effective at binding 
glycocholate. The most effective product was found to be 
dodecyl QA cellulose, which reduced the concentration of all 
of the bile salts to lower levels than any other ion 
exchanger. 
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CHAPTER 1. INTRODUCTION 
1.1 OUTLINE 
The object of this thesis was to produce a quaternary amino 
{QA) cellulose ion exchanger with potential for use as a bile 
acid sequestrant in the treatment of hypercholesterolemia. 
This introduction backgrounds the debilitating effects of 
hypercholesterolemic disorders and gives a brief summary of 
the clinical methods which are used to treat them. Treatments 
involving bile acid sequestrants, their mode of action and 
chemistry are reviewed. The procedures previously developed 
at Massey University for the preparation of cellulose ion 
exchangers are summarised. A rationale for the type of 
exchanger to be synthesised is given and the modifications 
considered necessary for promoting the selective and efficient 
binding of bile acids are discussed. 
1.2 EFFECTS OF ELEVATED PLASMA CHOLESTEROL 
It is now widely accepted that elevated plasma cholesterol is 
associated with coronary heart disease {CHD) 1 • In normal 
caucasians the total plasma cholesterol (TPC) level is 
approximately 200 mg/dL2 , but only a small fraction of this 
circulates as free cholesterol in the blood. Between 50-70% 
of TPC is transported between tissues as a low density 
lipoprotein {LDL) fraction, 20-45% as a high density 
lipoprotein {HDL) fraction, 5-10% as a very low density 
lipoprotein {VLDL) fraction and an insignificant amount in the 
chylomicrons 3 • Abnormally high levels of LDL {~-lipo-
proteins), and therefore cholesterol, can be associated with a 
number of diseases. This condition is classified as hyper-~-
lipoproteinemia and there are two recognised subtypes: type 
IIa and type IIb4 • Both of these subtypes result in premature 
CHD~. 
1 
Familial hypercholesterolemia (FH} is a relatively common 
inherited form of hyper-~-lipoproteinemia, which can be 
identified at birth. FH individuals have significantly 
elevated TPC and LDL levels (2-3 times greater than normal in 
heterozygotes and 4-6 times greater than normal in 
homozygotes}. The clinical consequences of unmanaged FH are 
well documented and include arcus coronae, xanthomas, marked 
atherosclerosis and premature CHD3 • 
1.3 GENERAL APPROACH TO CLINICAL MANAGEMENT OF 
HYPERCHOLESTEROLEMIA 
Substantial reductions, sometimes resulting in normalisation 
of TPC and LDL concentrations, can now be made in all forms of 
hyper-~-lipoproteinemia except for homozygous FH6 • Initial 
treatment involves adherence to a strictly controlled diet, 
followed by administration of hypolipidemic drugs where 
necessary (Table 1.1}. Altered diets (which limit cholesterol 
intake to less than 300 mg per day and are low in saturated 
fat} can be expected to reduce TPC and LDL levels by up to 
10%7 , but normalisation is still not achieved in some cases. 
Recent studies6 • 8 • 9 indicate that the most promising treatment 
of severe hyper-~-lipoproteinemia probably lies with combined 
treatment regimens, incorporating a bile acid sequestrant with 
complimentary drugs. 
2 
TABLE 1.1 Hypolipidemic Drugs Used in the Management of 
Plasma Cholesterol 6 
Mode of Action 
Nicotinic acid Inhibits secretion of VLDL {a precurser 
for LDL synthesis) 
Compactin 
Mevinolin 
Clofibrate 
Gemfibrozil 
Neomycin 
Cause competitive inhibition of the major 
rate limiting step of cholesterol 
biosynthesis 
Cause hydrolysis of VLDL triglycerides by 
lipoprotein lipase 
Inhibits reabsorption of bile acids {used 
where bile acid sequestrants are poorly 
tolerated) 
1.4 USE OF BILE ACID SEQUESTRANTS TO REDUCE PLASMA 
CHOLESTEROL LEVELS 
One well established method of treating hypercholesterolemia 
involves oral administration of non-absorbable anion 
exchangers which function as bile acid sequestrants. These 
materials have basic functional groups attached to a semi-
rigid polymer backbone and they operate by exchanging chloride 
ions for bile acid anions in the intestinal lumen10 , 11 • 
Bile acids are secreted into the duodenum in response to food 
intake, where they promote the absorption of dietary fat. The 
structure of the major bile acids and their distribution in 
human bile is given in Figure 1.112 • Ingestion of bile acid 
sequestrants increases the faecal excretion of bile acids and 
lowers their concentration in the intestine. This results in 
decreased absorption of dietary cholesterol and other lipids13 • 
It also causes an indirect decrease in plasma cholesterol, 
resulting from disruption of the enterohepatic circulation by 
which bile acids are reabsorbed. In healthy individuals 
approximately 95% of bile acids are actively reabsorbed from 
3 
the distal ileum and the remaining 5% are compensated for by 
new synthesis12 . However, under the conditions of bile acid 
sequestrant therapy fewer bile acids are reabsorbed, so an 
increased rate of synthesis must occur. Plasma cholesterol 
(from LDL) is the precurser for all new liver synthesis of 
bile acids 14 , therefore when bile acid sequestrants are used 
there is increased removal of plasma LDL and a corresponding 
decrease in TPC10 • 
Figure 1.1 Major Bile Acids Present in Human Bile8 
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a Bile acids are usually present in human bile as sodium 
or potassium salts, and they are conjugated with either 
glycine or taurine 
b Numbers refer to positions in the sterol ring 
4 
1.5 BILE ACID SEQUESTRANTS CURRENTLY AVAILABLE 
The ion exchangers which have been used for therapy are: 
A. Cholestyramine 
Cholestyramine, the most commonly used bile acid sequestrant, 
is or has been available as Cuemid (83% cholestyramine16 ), 
Questran (45% cholestyramine16 ) and Quantalan17 . It is a 
copolymer of styrene and 2% divinylbenzene, with quaternary 
amino groups attached using trimethylamine and balanced with 
chloride counterions (Figure 1.2A). 
B. Colestipol Hydrochloride 
Colestipol hydrochloride is a copolymer of diethylenetriamine 
and epichlorohydrin with approximately 20% of the available 
nitrogens titrated with hydrochloric acid (Figure 1.2B). It 
is sold under the proprietary name Colestid17 . 
C. Diethylaminoethyl (DEAE) Sephadex 
Polydexide or PDX chloride (formerly Secholex) is 79% DEAE-
Sephadex16. It is a dextran cross-linked with epichlorohydrin 
and orthosubstituted with 2-diethylaminoethyl (DEAE) groups, 
some of which are quaternised with 2-diethylaminoethyl 
chloride17 (Figure 1.2C). 
Cholestyramine based bile acid sequestrants (Questran and 
Cuemid) are usually preferred over other products (Colestid 
and Secholex) because they have superior capacity and binding 
kinetics for bile acids in vitro16 , 20 • Laboratory studies have 
demonstrated that Questran binds 40% more bile acids than 
Cuemid after mixing with bile for 2 hours at 37°C16 • In 
contrast, clinical studies show that the different bile acid 
sequestrants produce similar hypolipidemic effects in vivo21 ,-
22•23 Typically, the TPC in patients can be expected to drop 
by 20-25% more than that achieved with dietary control alone. 
This drop occurs in a very short time after administration of 
5 
the sequestrant and can be sustained indefinitely with 
continued use. 
Figure 1. 2 Partial Structures of Bile Acid Sequestrants 
Used in Therapy 
A. 
B. 
C. 
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1.6 SOME PROBLEMS ASSOCIATED WITH THE USE OF BILE ACID 
SEQUESTRANTS 
7 
Bile acid sequestrants are nonspecific and, as a result, a 
number of anions are able to compete with the bile acid anions 
for the available binding sites. The in vitro efficiency for 
binding bile acids in duodenal fluid is low for all of the 
sequestrants mentioned in Section 1.5, with only about 50% of 
the available ion exchange capacity being used under 
physiological conditions16 • The efficiency may be even less in 
vivo. Also small reductions of plasma cholesterol are 
compensated for by an increase in cholesterol biosynthesis10 • 
Thus for effective therapy prolonged and/or large dose rates 
are required17 • 
Since the ion exchangers are not absorbed from the gastro-
intestinal tract no systemic ill effects can be expected. 
Nevertheless, prolonged therapeutic treatment (e.g. 16-20 g 
cholestyramine per 24 hours) commonly results in constipation 
(10-50% incidence) and can sometimes lead to nausea, vomiting 
and other gastrointestinal discomfort. Because normal fat 
absorption is impaired, malabsorption of fat soluble vitamins 
may also occur, leading to side-effects including 
lypocalcemia, hypothrombonemia and/or folic acid 
deficiency10 • 11 • Considerable work has therefore focused on 
making bile acid sequestrants more effective. 
The bile acid binding capacity of cholestyramine is enhanced 
by the addition of taurine and its 'pharmaceutically accepted' 
salts20 , ascorbic acid26 and some essential fatty acids 27 • 
Cholestyramine resins with different mesh sizes have been 
tested, however while finer particle sizes were less gritty 
and more palatable, their in vivo efficiency in binding bile 
acids was not improved over the standard grade28 • More recent 
studies have attempted to make cholestyramine more palatable 
by the addition of CM-cellulose, Primogel, lactose and 
flavours 29 • Also, formulations incorporating dietary fiber and 
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citric acid have been shown to eliminate the mouthfeel and 
taste of ion exchange drugs 30 • These studies point to the need 
for the development of new sequestrants which have superior 
ion exchange capacity and higher selectivity for binding bile 
acids. 
1.7 THE USE OF HP INDION CELLULOSE MATRIX FOR THE 
PREPARATION OF ION EXCHANGERS 
Earlier work by Dr J.S. Ayers at Massey University has 
demonstrated that the chemical modification of cellulose can 
produce materials suitable for derivatisation and subsequent 
use as chromatography media. These studies demonstrated that 
hydroxypropylated regenerated cellulose (now available as HP 
Indiona) was an acceptable starting matrix for the preparation 
of ion exchangers31 • Some of the HP Indion ion exchangers 
produced locally have proved to be ideal for large scale 
protein separation32 , because they are resiliant to both 
chemical and physical attrition, and have high capacities for 
binding macromolecules31 • 
HP Indion is prepared from regenerated cellulose, which is 
first ground and then graded into different particle sizes. 
Next it is swollen with propylene oxide and cross-linked with 
epichlorohydrin in the presence of sodium hydroxide, according 
to the method first described by Sheerin33 • Typical groups 
present in the HP Indion cellulose matrix are shown in 
Equation 1.1. HP Indion is available in a range of particle 
sizes and degrees of cross-linking34 • 
a Waitaki International Biosciences, Christchurch 
Equation 1.1 Preparation of HP Indion from Regenerated 
Cellulose 
OH 
9 
OH 
OH 
0 
/\ 
CH2-CH-CH3 
NaOH 
I 
O-CH2 -CH-CH3 
OH 
Hydroxypropyl 
Group 
OH 
OH HO~ 
Regenerated 
Cellulose 
0 
/\ Cl -CH2-CH-CH2 
NaOH 
HP Indion 
Chemical 
Cross-Link 
1.8 EPOXIDE ACTIVATION OF HP INDION CELLULOSE MATRIX 
One very effective method of preparing ion exchangers from the 
cellulosic HP Indion starting matrix involves epoxide 
activation (Equation 1.2) and coupling (Equation 1.5). 
Equation 1.2 Epoxide Activation 
NaOH 
Cold 
HP Indion Epoxide Activated Cellulose 
The conditions needed to substitute the maximum number of 
epoxide groups onto the cellulose matrix have been thoroughly 
investigated30 . The critical factor affecting the level of 
epoxidation relates to the ratio of sodium hydroxide and 
epichlorohydrin used. Sodium hydroxide is consumed by 
epichlorohydrin in a 1:1 mole ratio in order to react with the 
cellulose matrix, and also through hydrolysis (Equation 1.3). 
Equation 1.3 Hydrolysis of Epichlorohydrin 
10 
Once the sodium hyroxide has been consumed further activation 
is not possible no matter how much epichlorohydrin is used. 
However, if excess sodium hydroxide is used hydrolysis of the 
active epoxide groups occurs (Equation 1.4). 
Equation 1.4 Hydrolysis of Activated Cellulose by Excess 
Sodium Hydroxide 
0 OH OH L / \ I I 
,o-CH2-CH-CH2 + H20 + NaOH _.... t0-CH2-CH-CH2 + NaOH 
Epoxide Activated 
Cellulose 
Hydrolysis 
Product 
In order to produce the maximum number of active epoxides a 
25% molar excess of epichlorohydrin over sodium hydroxide must 
be used. A 6-8% w/v solution of sodium hydroxide is also 
essential: above this concentration extra weight is added to 
the cellulose without a significant increase in the number of 
epoxides produced (indicating that hydrolysis had occured); 
but when less than 6% soidum hydroxide is used limited 
epoxidation results. The actual volume of sodium hydroxide 
solution, and the number of active epoxides produced, 
ultimately depends on the physical properties of the HP Indion 
used. Other factors influencing the number of epoxides 
produced are the temperature and time of the reaction. 
Maximum epoxidation (up to 1.4 meq/g) is obtained by 
activating at low temperatures, however the time required for 
the reaction to reach completion at 4°C is in excess of 30 
hours. 
It is possible to couple a wide variety of functional groups 
to epoxide activated HP Indion (Table 1.2). Previous work 
demonstrated that amino cellulose ion exchangers were 
moderately effective at binding bile acid anions in vitro36 • 
However, this work was limited and synthetic methods for 
optimising the ion exchange function were not investigated. 
Table 1. 2 Ion Exchangers Prepared from Epoxide Activated 
HP Indion 
Ion Exchanger 
Sulphopropyl (SP) cellulose 
Phosphate (PT) cellulose 
Quaternary Amino (QA) cellulose 
Tertiary Amino (DE) cellulose 
Primary Amino (PA) cellulose 
1.9 AIM OF THESIS 
Structure 
-SOa-Na+ 
-PO<t-Na+ 
-NRa+c1-
-NHR2+c1-
-NH3+c1-
Function 
Cation 
Exchange 
Anion 
Exchange 
Bile acid sequestrants operate by exchanging negatively 
charged counterions {usually chloride ions) for bile acid 
anions, hence it was anticipated that quaternary amino {QA) 
cellulose ion exchangers would be effective because they 
remain charged at all pH levels. Therefore it was decided to 
prepare a range of dimethylalkyl QA celluloses by coupling 
N,N-dimethyl-N-alkylamines to epoxide activated HP Indion as 
shown in Equation 1.5. 
The aim was to identify the most effective alkyl group, and 
then optimise the synthesis of the cellulose ion exchanger. 
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It was hoped that the capacity of the resultant product to 
bind bile acids in vitro would match or exceed that of 
cholestyramine. Ultimately it was hoped that a cellulose based 
drug would alleviate some of the side-effects which occur with 
the synthetic polystyrene matrix of cholestyramine. 
Equation 1.5 Preparation of Quaternary Amino {QA) 
Cellulose (Coupling) 
+ 
Epoxide Activated 
Cellulose 
CHa 
I 
N-R + 
I 
CHa 
OH CH3 
L I I H2 0 -- 1O-CH2 -CH-CH2 -N+ -R I 
CH3 
Dimethylalkyl QA 
Cellulose 
OH-
